GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Cash Flow from Others

Concord Biotech (BOM:543960) Cash Flow from Others : ₹-1,195 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Cash Flow from Others?

Concord Biotech's cash flow from others for the six months ended in Mar. 2024 was ₹-750 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-1,195 Mil.


Concord Biotech Cash Flow from Others Historical Data

The historical data trend for Concord Biotech's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Cash Flow from Others Chart

Concord Biotech Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Cash Flow from Others
-583.15 -846.63 -580.40 -777.59 -1,195.10

Concord Biotech Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Cash Flow from Others Get a 7-Day Free Trial - -180.11 -597.50 -445.28 -749.81

Concord Biotech Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-1,195 Mil.

Concord Biotech Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Concord Biotech's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Biotech (BOM:543960) Business Description

Traded in Other Exchanges
Address
Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines